ciltacabtagene autoleucel
janssen,legend bio
day 3 #ims2022 oral abstract session nct04133636: phase 2 - study of jnj-68284528, car-t therapy directed against bcma in mm -cartitude-2 #mmsm #multiplemyeloma #curemyeloma 
Multiple Myeloma Education Platform for Myeloma Community